Atlas Trials

Phase 1 Study of E7090 in Subjects With Solid Tumor

Clinical trial NCT02275910 · COMPLETED

Trial details

NCT number
NCT02275910
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tumors
Start date
2014-10-28
Primary completion
2021-09-03
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.